PrimeCell Therapeutics is a Czech biotechnology company specializing in regenerative medicine and advanced therapies. They develop and manufacture medicinal products using human cells and new materials to treat serious diseases. Their focus areas include somatic-cell therapy, tissue engineering, stem cell treatment, and nanomaterials. They are also developing regenerative therapies for wound care and have a flagship product called Amnioderm for chronic wounds. They collaborate with scientific institutions and are expanding their production capacity with a biotechnology park.